Thursday 24 March 2022

07.30-08.30 | Lobby Crowne Plaza 
Registration participants 

08.30-10.00 | Room Ceramique 1+2
Theme 3: How to limit bleeding risks: insights from translational studies 

Chairpersons: Judith Cosemans, Hugo ten Cate 
• Genetics and bleeding disorders - Kathleen Freson
• Genetics and antithrombotics: individual drug tailoring? - Jur ten Berg
• Clinical rationale for antagonizing antithrombotic agents in bleeding patients - Peter Verhamme
• Novel reversal agents - Joost Meijers 

10.00-10.30 | Coffee break | Exhibition area

10.30-11.30 | Workshops | Room Macon & Pommard
Workshop 5: Genetics on bleeding & antithrombotics | Room Macon
Kathleen Freson
Jur ten Berg

Workshop 6: Antagonizing & reversal | Room Pommard
Peter Verhamme
Joost Meijers

11.30-12.00 | Short break | Exhibition area 

12.00-13.00 | Room Ceramique 1+2
Consensus discussion

13.00-14.00 | Lunch | Restaurant 

14.00-15.30 | Room Ceramique 1+2
Theme 4: Hemostasis in extracorporeal systems: how to utilize ex vivo models?

Chairpersons: Paola van der Meijden, Kerstin Jurk
• How to assess hemostasis ex vivo? - Paola van der Meijden 
• Microfluidic systems to study thrombosis and hemostasis - Wilbur Lam
• Extracorporeal circuits and hemostatic challenges - Roberto Lorusso
• Generating novel vascularised organoids for disease modelling and drug development - Abdullah Khan

15.30-16.00 | Coffee break | Exhibition area 

16.00-17.00 | Workshops | Room Macon & Pommard
Workshop 7: Hemostasis ex vivo & microfluidic systems | Room Macon
Paola van der Meijden
Wilbur Lam

Workshop 8: Extracorporeal circuits & novel vascularised organoids | Room Pommard
Roberto Lorusso
Abdullah Khan

17.00-17.30 | Short break | Exhibition area 

17.30-18.00 | Room Ceramique 1+2
Consensus discussion

18.00-18.30 | Room Ceramique 1+2
Keynote Ticardio/MCCT: Ambivalent roles of leukocyte-derived microvesicles in haemostasis | Francoise Dignat George

Introduced by Wolfram Ruf and Hugo ten Cate